Bioavailability of BI 1356 After Single Oral Administration Given as Different Tablet Formulation in Healthy Male Volunteers
NCT02183363 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24
Last updated 2014-07-08
Summary
Study to investigate the relative bioavailability of 5 mg BI 1356 as tablet formulations (Trial formulation) TF II and Intended final formulation (iFF) vs. 5 mg BI 1356 as tablet TF IIb
Conditions
- Healthy
Interventions
- DRUG
-
BI 1356 - Tablet TFII
- DRUG
-
BI 1356 - Tablet iFF
- DRUG
-
BI 1356 - Tablet TFIIb
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 21 Years
- Max Age
- 55 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2007-02-28
- Primary Completion
- 2007-05-31
More Related Trials
-
Investigation of the Metabolism and Pharmacokinetics of 10 mg [14C] BI 1356 Administered Orally Compared to 5 mg [14C] BI 1356 Administered Intravenously in Healthy Male Volunteers
NCT02183610 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics and Pharmacodynamics of Multiple 5 mg Doses of BI 1356 p.o. Given Once Daily Compared to Multiple 2.5 mg Doses Given Twice Daily in Healthy Male and Female Volunteers
NCT02173652 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Bioavailability of Two Newly Developed Tablet Formulations (TF2 and iFF)Compared to BI 1060469 TF1 Formulation, Following Oral Administration (Low and High Dose)in Healthy Female Subjects
NCT02438696 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability of 3 Different Formulations of BI 207127 in Healthy Male Volunteers
NCT01535638 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Bioavailability of BI 201335 Capsule Versus Three Different Oral Solutions
NCT01764945 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability of BI 1356 After Co-administration With Ritonavir Compared to the Bioavailability of BI 1356 Alone in Healthy Male Volunteers
NCT02183441 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Rising Oral Doses and Multiple Rising Oral Doses of BI 1356 BS in Healthy Male Volunteers
NCT02183311 ·Status: COMPLETED ·Phase: PHASE1
-
The Effect of Multiple Oral Doses of BI 1356 BS on Pharmacokinetics, Safety and Tolerability of Multiple Oral Doses of Simvastatin and on the Pharmacokinetics of Its Metabolite Simvastatin Acid in Healthy Male Volunteers
NCT02183623 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics of Single and Multiple Oral Doses of BI 1356 in Healthy Chinese Volunteers
NCT02183532 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability and Pharmacokinetics of BI 135585 XX Administered as Tablet With and Without Food
NCT01286571 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy People to Compare 2 Different Formulations of BI 1358894 Tablets Taken With or Without Food
NCT05155306 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics and Relative Bioavailability of 11634 Immediate Release Tablet in Healthy Male Volunteers
NCT02214927 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability of Four Oral Prototype Extended Release Formulations With BI 11634 in Healthy Male Volunteers
NCT02214953 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Bioavailability of a BI 187004 Tablet Formulation in Comparison With an Oral Solution and the Influence of Food on the Tablet Formulation in Healthy Volunteers
NCT02161432 ·Status: COMPLETED ·Phase: PHASE1
-
To Investigate the Safety, Tolerability, Pharmacokinetics and the Relative Bioavailability of BI 1026706
NCT01763333 ·Status: COMPLETED ·Phase: PHASE1
-
Safety of Single Rising Doses and Relative Bioavailability of BI 691751
NCT01843972 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Pharmacokinetics of Single Rising Oral Doses of BI 224436 ZW in Healthy Male Volunteers.
NCT02183662 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability of Warfarin After Coadministration With Multiple Doses of BI 1356 Compared to the Bioavailability of Warfarin Alone in Healthy Male Volunteers
NCT02183389 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
NCT04065295 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics of Single Rising Oral Doses of BI 1181181 in Healthy Male Volunteers, Including Investigation of the Effect of Food on the Bioavailability of BI 1181181
NCT02044406 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability of BI 1356 With and Without Co-administration of Pioglitazone and the Bioavailability of Pioglitazone With and Without Coadministration of BI 1356 in Healthy Male and Female Volunteers
NCT02183337 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Bioavailability, Safety and Tolerability of Two Tablet Formulations of BIIL 284 BS
NCT02265666 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men to Test if Taking Different Formulations of BI 1358894 With or Without Food Influences the Amount of BI 1358894 in the Blood
NCT03892616 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy People to Compare 2 Different Formulations of BI 1015550 Taken With or Without Food
NCT05428436 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Bioavailability Study in Healthy Subjects to Evaluate the Pharmacokinetics of HTL0009936 After One Dose of Prototype Formulation
NCT02710188 ·Status: COMPLETED ·Phase: PHASE1